Atlas Trials

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Clinical trial NCT04056247 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04056247
Sponsor
OncoHost Ltd.
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung CancerStage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant Melanoma
Start date
2019-10-01
Primary completion
2029-10-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.